Table 3

Domain scores of the nine guidelines assessed by using the AGREE-II instrument (%)

Domain 191.798.691.790.397.284.786.187.573.690.391.781.988.8±6.5
Domain 385.962.551.±22.6
Domain 498.698.698.694.494.487.580.683.391.788.994.488.991.7±5.7
Domain 585.464.661.526.038.525.057.337.524.039.629.227.143.0±18.9
Domain 681.389.631.364.625.±36.1
  • Domain 1: scope and purpose; domain 2: stakeholder involvement; domain 3: rigour of development; domain 4: clarity of presentation; domain 5: applicability; domain 6: editorial independence.

  • AAP, American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (America); AGREE, Appraisal of Guidelines for Research & Evaluation; ChPS, Chinese Pediatric Society, Chinese Medical Association (China); CPS, Canadian Pediatric Society, Fetus and Newborn Committee (Canada); INS, Israel Neonatal Society (Israel); ISN, Italian Society of Neonatology (Italy); MaHTAS, Malaysia Health Technology Assessment Section (Malaysia); NICE, National Institute for Health and Care Excellence (the UK); NPA, Norwegian Pediatric Association (Norway); QCG, Queensland Clinical Guidelines (Australia); SAP, Spanish Association of Pediatrics (Spain); SSN, Swiss Society of Neonatology (Swiss); TPA, Turkish Pediatric Association (Turkey).